Detalhe da pesquisa
1.
Overall survival with [177Lu]Lu-PSMA-617 versus cabazitaxel in metastatic castration-resistant prostate cancer (TheraP): secondary outcomes of a randomised, open-label, phase 2 trial.
Lancet Oncol
; 25(1): 99-107, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38043558
2.
[177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 25(5): 563-571, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38621400
3.
Can 68 Ga-PSMA positron emission tomography and multiparametric MRI guide treatment for biochemical recurrence after radical prostatectomy?
BJU Int
; 132(3): 321-328, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37190993
4.
[177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial.
Lancet
; 397(10276): 797-804, 2021 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33581798
5.
68Ga-Prostate-Specific Membrane Antigen Positron Emission Tomography Maximum Standardized Uptake Value as a Predictor of Gleason Pattern 4 and Pathological Upgrading in Intermediate-Risk Prostate Cancer.
J Urol
; 207(2): 341-349, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546815
6.
Detection and localisation of primary prostate cancer using 68 gallium prostate-specific membrane antigen positron emission tomography/computed tomography compared with multiparametric magnetic resonance imaging and radical prostatectomy specimen pathology.
BJU Int
; 126(1): 83-90, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31260602
7.
Neuraxial Anesthesia Reduces Lymphatic Flow: Proof-of-Concept in First In-Human Study.
Anesth Analg
; 123(5): 1325-1327, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27636740
8.
Combined Utility of 68Ga-Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging in Predicting Prostate Biopsy Pathology.
Eur Urol Oncol
; 5(3): 314-320, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741337
9.
68 Ga-prostate-specific membrane antigen (PSMA) PET/CT as a clinical decision-making tool in biochemically recurrent prostate cancer.
Asia Pac J Clin Oncol
; 18(5): e204-e210, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161628
10.
177Lu-octreotate, alone or with radiosensitising chemotherapy, is safe in neuroendocrine tumour patients previously treated with high-activity 111In-octreotide.
Eur J Nucl Med Mol Imaging
; 37(10): 1869-75, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20445977
11.
No needle to fear: An approach to needle phobic patients.
Asia Ocean J Nucl Med Biol
; 8(2): 160-163, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32715008
12.
Atypical brown fat distribution in young males demonstrated on PET/CT.
Clin Nucl Med
; 32(9): 679-82, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17710017
13.
Neurolymphomatosis: an uncommon manifestation of lymphoma - detection and therapeutic monitoring through 18F-fluorodeoxyglucose positron-emission tomography and computed tomography imaging.
BMJ Case Rep
; 15(5)2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35537764
14.
Utility of SUVmax on 18 F-FDG PET in detecting cervical nodal metastases.
Cancer Imaging
; 16(1): 39, 2016 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27821180
15.
Dynamic four-dimensional computed tomography for preoperative assessment of lung cancer invasion into adjacent structures.
Eur J Cardiothorac Surg
; 47(2): 239-43; discussion 243, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25082145
16.
Intravascular small cell neuroendocrine tumor in the neck.
Clin Nucl Med
; 39(11): 988-9, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24978335
17.
Preliminary experience of 18F-fluorodeoxyglucose positron emission tomography in Castleman's disease.
Leuk Lymphoma
; 47(12): 2664-6, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17169817
18.
High-administered activity In-111 octreotide therapy with concomitant radiosensitizing 5FU chemotherapy for treatment of neuroendocrine tumors: preliminary experience.
Cancer Biother Radiopharm
; 24(5): 527-33, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-19877882
19.
Clinical experience with the first combined positron emission tomography/computed tomography scanner in Australia.
Med J Aust
; 182(4): 172-6, 2005 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-15720173